Researchers uncovered how cells selectively destroy certain microRNAs — key gene regulators — through a mechanism that requires two RNA signals working together.
TriCares announced today that it received FDA investigational device exemption (IDE) to study its Topaz heart valve replacement system.
A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil.
People whose sleep apnea changes dramatically from night to night are 30% more likely to have a heart attack, stroke, or heart failure, reveals a new study from Flinders University.
The Advanced Research Projects Agency for Health (ARPA-H) said several experimental treatments could help regrow cartilage and bone in folks with osteoarthritis.
An advanced version of a procedure using magnetic fields to stimulate brain nerve cells in treating depression was significantly effective for 85% of active military and veterans suffering from combat post-traumatic stress disorder enrolled in a recent study, when added to psychotherapy.
Researchers at NYU Abu Dhabi have developed smart molecules that can both detect and treat cancer, offering a safer and more precise approach to care.
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized.
A virus that typically infects marine animals, such as shrimp and fish, has jumped to humans and is causing chronic eye disease in some people, according to a study published in the journal Nature Microbiology.
Encouraging 12-month pilot clinical study results will be presented by Key Opinion Leader Dr. Lowell Kabnick at the prestigious Charing Cross Vascular Symposium in London on Tuesday, April 21st, 2026.